Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Clinical Efficacy and Prognostic Analysis of Omadacycline in the Treatment of Mycobacterium Abscessus Pulmonary Disease.

NCT07615309 is registered in ClinicalTrials.gov with Beijing Chest Hospital as lead sponsor.

NCT NCT07615309
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07615309 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Clinical Efficacy and Prognostic Analysis of Omadacycline in the Treatment of Mycobacterium Abscessus Pulmonary Disease.
Lead sponsor
Beijing Chest Hospital
Phase
Observational
Overall status
Enrolling by invitation
Start date
January 1, 2014
Completion date
December 31, 2029
Enrollment
200 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

mycobacterium abscessus infection, ntm lung infection due to mac